Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection

Clinical trial NCT02081079 · COMPLETED

Trial details

NCT number: NCT02081079
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Genotype 4 HCV Chronic Genotype 5 HCV

Start date: 2014-03-01
Primary completion: 2014-11-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.